Jommi, C.; Bonfanti, M.; Guardigni, M.; Aiello, A.; Marcellusi, A.; Canonico, P.L.; Luccini, F.; Lucchetti, C.
Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past? J. Mark. Access Health Policy 2025, 13, 37.
https://doi.org/10.3390/jmahp13030037
AMA Style
Jommi C, Bonfanti M, Guardigni M, Aiello A, Marcellusi A, Canonico PL, Luccini F, Lucchetti C.
Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past? Journal of Market Access & Health Policy. 2025; 13(3):37.
https://doi.org/10.3390/jmahp13030037
Chicago/Turabian Style
Jommi, Claudio, Marzia Bonfanti, Melissa Guardigni, Andrea Aiello, Andrea Marcellusi, Pier Luigi Canonico, Fulvio Luccini, and Chiara Lucchetti.
2025. "Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past?" Journal of Market Access & Health Policy 13, no. 3: 37.
https://doi.org/10.3390/jmahp13030037
APA Style
Jommi, C., Bonfanti, M., Guardigni, M., Aiello, A., Marcellusi, A., Canonico, P. L., Luccini, F., & Lucchetti, C.
(2025). Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past? Journal of Market Access & Health Policy, 13(3), 37.
https://doi.org/10.3390/jmahp13030037
